Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Asston Pharmaceuticals has informed that it enclosed the certificate for the quarter ended 30th September, 2026, as received from the Registrar and Share Transfer Agent of the Company, Maashitla Securities.
The above information is a part of company’s filings submitted to BSE.